Eli Lilly CEO rebuts Amodei's medical claims
substack.com

Eli Lilly CEO rebuts Amodei's medical claims

Archived — this story has rotated out of today’s deck. It is kept here in full.

The gist

Eli Lilly CEO Dave Ricks said Anthropic CEO Dario Amodei's forecast of curing major diseases within a decade is "not likely."
The pushback came during Anthropic's IPO roadshow, testing how AI health promises meet drug-development reality.

Background

Dario Amodei is CEO of Anthropic, an AI company whose IPO (initial public offering, when a company lists shares on a stock exchange) roadshow was underway. In a roadshow video, Amodei said cancer, Alzheimer's, heart disease and mental illness would be "relics of the past" in less than a decade. Dave Ricks, Chairman and CEO of drugmaker Eli Lilly and Company, pushed back, and other biotech figures followed after health journalist Meg Tirrell asked experts to weigh in.

How it unfolded

  1. Nov 10, 2026Anthropic CEO Dario Amodei's IPO roadshow video claims cancer, Alzheimer's, heart disease and mental illness will be "relics of the past" in "less than a decade."
  2. Nov 10, 2026Health journalist Meg Tirrell asks bio experts to weigh in on Amodei's forecast.
  3. Nov 11, 2026Eli Lilly CEO Dave Ricks responds that the vision would be "amazing" but is "not likely," saying the map of biology is "still largely a blank page" and randomized human proof is "the long pole in the tent."
  4. Nov 12, 2026Anthropic's IPO is reported to be roughly six times oversubscribed, cited to Bloomberg and unnamed sources.
  5. Nov 13, 2026Telecare Aware's weekly AI roundup criticizes Amodei's claim as "pure hype."

Key terms

IPO roadshow
A process in which shares of a company are sold to institutional and retail investors, often to raise capital and become publicly traded.
Gantt chart
A bar chart that illustrates a project schedule, showing task start and end times and dependencies.

Source: Wikipedia

Who’s saying what

Caution
Eli Lilly CEO Dave Ricks called the vision "amazing" but "not likely," saying biology is "still largely a blank page" and randomized human proof is "the long pole in the tent."
Expert
Cardiologist and AI-health optimist Eric Topol said curing all these diseases in 10 years is "impossible" and sets "an unattainable objective," though he is optimistic about AI improving health.
Analysts
Atlas Venture partner Bruce Booth said AI will compress development timelines by only 10% to 20%, since "a 52-week study still takes 52 weeks."
Bulls
Self-described AI bull Rod Wong said someone ought to send Amodei "a drug-development Gantt chart."

Still unverified

The roughly six-times oversubscription figure for Anthropic's IPO is attributed to Bloomberg citing unnamed sources.

Sources

See today’s stories in the app Gistline — free on the App Store